Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil
National Center for Advancing Translational Sciences
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil
Haley Hedlin, Stephen P. Luby, Di Lu, Denise Oliveira GARRET et al.
Citations
2 citations
Journal
BMJ Public Health
Topics
SARS-CoV-2 and COVID-19 Research
Field-Weighted Citation Impact (FWCI)
2.79
article
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil
Haley Hedlin, Stephen P. Luby, Di Lu, Denise Oliveira GARRET, Patrícia Vieira da Silva, Vivek Charu, Roberto Dias de Oliveira, Jessica Couvillion Seidman, Amy Zhang, Marco Antonio Moreira Puga, Blake Shaw, Joelle I. Rosser, Júlio Croda, Victor Ritter, Farah Naz Qamar, Alice Carter, Juliana Barros Verruck
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ Public HealthVol. 3(2)
Institutions
Aga Khan University (PK), Universidade Federal de Mato Grosso do Sul (BR), Universidade Estadual de Mato Grosso do Sul (BR), Stanford Medicine (US), Berkeley Public Health Division (US), Sabin Vaccine Institute (US), Fundação Oswaldo Cruz (BR), University of California, Berkeley (US), Stanford University (US)
Funders
Sabin Vaccine Institute, Coalition for Epidemic Preparedness Innovations, National Institutes of Health, Stanford Bio-X, National Center for Research Resources, National Center for Advancing Translational Sciences